share_log
Moomoo 24/7 ·  Mar 25 08:16
Matinas BioPharma Announces Results From An Additional In Vivo Study In Healthy Mice With An Oral LNC Formulation Of Docetaxel, A Chemotherapeutic Agent Used In The Management Of Multiple Metastatic And Unresectable Tumors
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment